載入...
Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab
BACKGROUND: Pertuzumab, a human epidermal growth factor receptor (HER) 2 dimerization inhibitor, has demonstrated promising efficacy in combination with trastuzumab in patients with metastatic breast cancer. As HER signaling pathways are not only involved in oncogenesis, but also in myocardial homeo...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3331733/ https://ncbi.nlm.nih.gov/pubmed/21665955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdr294 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|